Impact of maternal height, booking weight and gestational weight gain on cardiac adaptation in pregnancy

2022 ◽  
Author(s):  
H. Z. Ling ◽  
P. Garcia Jara ◽  
K. H. Nicolaides ◽  
N. A. Kametas
Keyword(s):  
Weight Gain ◽  
Gestational Weight Gain ◽  
Maternal Height ◽  
Gestational Weight ◽  
Cardiac Adaptation ◽  
In Pregnancy

scholarly journals Lower education predicts poor response to dietary intervention in pregnancy, regardless of neighbourhood affluence: secondary analysis from the ROLO randomised control trial

2017 ◽  
Vol 20 (16) ◽  
pp. 2959-2969 ◽  
Author(s):  
Eileen C O’Brien ◽  
Goiuri Alberdi ◽  
Aisling A Geraghty ◽  
Fionnuala M McAuliffe
Keyword(s):  
Weight Gain ◽  
Gestational Weight Gain ◽  
Dietary Intervention ◽  
Randomised Control Trial ◽  
Control Group ◽  
Education Session ◽  
Neighbourhood Deprivation ◽  
Gestational Weight ◽  
Dietary Education ◽  
In Pregnancy

AbstractObjectiveTo determine if response to a low glycaemic index (GI) dietary intervention, measured by changes in dietary intake and gestational weight gain, differed across women of varying socio-economic status (SES).DesignSecondary data analysis of the ROLO randomised control trial. The intervention consisted of a two-hour low-GI dietary education session in early pregnancy. Change in GI was measured using 3 d food diaries pre- and post-intervention. Gestational weight gain was categorised as per the 2009 Institute of Medicine guidelines. SES was measured using education and neighbourhood deprivation.SettingThe National Maternity Hospital, Dublin, Ireland.SubjectsWomen (n 625) recruited to the ROLO randomised control trial.ResultsThe intervention significantly reduced GI and excess gestational weight gain (EGWG) among women with third level education residing in both disadvantaged (GI, mean (sd), intervention v. control: −3·30 (5·15) v. −0·32 (4·22), P=0·024; EGWG, n (%), intervention v. control: 7 (33·6) v. 22 (67·9); P=0·022) and advantaged areas (GI: −1·13 (3·88) v. 0·06 (3·75), P=0·020; EGWG: 41 (34·1) v. 58 (52·6); P=0·006). Neither GI nor gestational weight gain differed between the intervention and control group among women with less than third level education, regardless of neighbourhood deprivation.ConclusionsA single dietary education session was not effective in reducing GI or gestational weight gain among less educated women. Multifaceted, appropriate and practical approaches are required in pregnancy interventions to improve pregnancy outcomes for less educated women.

Antenatal body mass index (BMI) and weight gain in pregnancy – its association with pregnancy and birthing complications

2016 ◽  
Vol 44 (4) ◽  
Author(s):  
Josefine Theresia Maier ◽  
Elisabeth Schalinski ◽  
Ulrich Gauger ◽  
Lars Hellmeyer
Keyword(s):  
Weight Gain ◽  
Gestational Weight Gain ◽  
Overweight And Obesity ◽  
Labor Induction ◽  
Reproductive Age ◽  
Common Finding ◽  
Pregnancy Weight Gain ◽  
Gestational Weight ◽  
Pregnancy Weight ◽  
In Pregnancy

AbstractOverweight and obesity is a serious health risk in both developed and developing nations. It is a common finding among women in their reproductive age. Half of patients entering their pregnancy in the US have a BMI >25.0 and therefore qualify as overweight or obese. Moreover, there is a tendency towards increased weight gain during pregnancy. Studies have shown that gestational overweight is associated with complications in pregnancy and birthing as well as short-term and long-term impacts on neonatal outcome in childhood and adulthood.Five hundred and ninety-one women visiting our tertiary perinatal center in 2014 were analyzed for antenatal BMI, gestational weight gain, as well as pregnancy outcome and complication together with neonatal weight and outcome. Pregnancy weight gain was assessed based on the IOM guidelines (Institute of Medicine) issued in 2009.Twenty-nine percent of our population was overweight with a BMI of more than 25.0. The general weight gain was in every BMI group similar (median ranging from 12.0 to 14.0 kg). Approximately one third gained more than the appropriate amount (37%, P<0.001). Women with more gestational weight were at risk of labor induction (55.0% vs. 45.7% labor induction in total, P=0.007). Strikingly, those patients were found to have significantly higher rates of secondary cesarean section (22.4% vs. 15.4%) and decreased chances of spontaneous vaginal birth (57.5% vs. 61.4%) (P=0.008). Furthermore women with a pregnancy weight gain in excess of the guidelines gave birth to neonates with a higher birth weight (>75.centile, 28.3% vs. 21.3%, P<0.001).Altogether, one third of the analyzed population is already overweight or obese when entering pregnancy. A higher gestational weight gain than the recommended amount was found in 37% of cases. We found an association with pregnancy and birthing complications as well as higher infant weight. This highlights the importance of preconceptive and prenatal advice, and if necessary, intervention on BMI and weight gain.

scholarly journals Reducing Excessive Gestational Weight Gain: Lessons from the Weight Control Literature and Avenues for Future Research

2011 ◽  
Vol 7 (6) ◽  
pp. 641-661 ◽  
Author(s):  
Suzanne Phelan ◽  
Kris Jankovitz ◽  
Todd Hagobian ◽  
Barbara Abrams
Keyword(s):  
Weight Gain ◽  
Gestational Weight Gain ◽  
Weight Control ◽  
Future Research ◽  
Self Monitoring ◽  
Gestational Weight ◽  
Excessive Gestational Weight Gain ◽  
Daily Diet ◽  
Potential Applications ◽  
In Pregnancy

Excessive gestational weight gain is a prevalent problem and an independent predictor of future obesity in both mothers and offspring. Intervention research to prevent excessive gestational weight gain is still in its infancy but results to date have been quite modest. Research in weight control outside of pregnancy over the past 30 years has been more robust and identified several key components of effective programs, including use of caloric restriction, daily diet self-monitoring, self-weighing, behavior therapy and ongoing patient–provider contact. The aim of this article is to summarize intervention components shown to be effective in promoting successful weight control outside of pregnancy and explore potential applications in pregnancy. Available evidence suggests that the strategies shown to be effective for weight control outside of pregnancy may also promote better weight control in pregnancy, but several lines for future investigation remain.

scholarly journals Evaluation of an activity monitor for use in pregnancy to help reduce excessive gestational weight gain

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Paul M. C. Lemmens ◽  
Francesco Sartor ◽  
Lieke G. E. Cox ◽  
Sebastiaan V. den Boer ◽  
Joyce H. D. M. Westerink
Keyword(s):  
Weight Gain ◽  
Gestational Weight Gain ◽  
Activity Monitor ◽  
Gestational Weight ◽  
Excessive Gestational Weight Gain ◽  
In Pregnancy

603: PPARG expression varies with excess gestational weight gain (GWG) in pregnancy: An important target in developmental programming

2018 ◽  
Vol 218 (1) ◽  
pp. S360
Author(s):  
Niraj R. Chavan ◽  
Leryn J. Reynolds ◽  
Kristin McQuerry ◽  
Arnold Stromberg ◽  
Kevin J. Pearson ◽  
...  
Keyword(s):  
Weight Gain ◽  
Gestational Weight Gain ◽  
Developmental Programming ◽  
Gestational Weight ◽  
Important Target ◽  
Pparg Expression ◽  
In Pregnancy

scholarly journals Bump2Baby and Me: protocol for a randomised trial of mHealth coaching for healthy gestational weight gain and improved postnatal outcomes in high-risk women and their children

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Sharleen L. O’Reilly ◽  
Christy Burden ◽  
Cristina Campoy ◽  
Fionnuala M. McAuliffe ◽  
Helena Teede ◽  
...  
Keyword(s):  
Weight Gain ◽  
High Risk ◽  
Usual Care ◽  
Gestational Weight Gain ◽  
Early Pregnancy ◽  
Evidence Based ◽  
Non Communicable Diseases ◽  
Gestational Weight ◽  
Pregnancy And Postpartum ◽  
In Pregnancy

Abstract Background Gestational diabetes (GDM) impacts 8–18% of pregnancies and greatly increases both maternal and child risk of developing non-communicable diseases such as type 2 diabetes and obesity. Whilst lifestyle interventions in pregnancy and postpartum reduce this risk, a research translation gap remains around delivering implementable interventions with adequate population penetration and participation. Impact Diabetes Bump2Baby is an implementation project of an evidence-based system of care for the prevention of overweight and obesity. Bump2Baby and Me is the multicentre randomised controlled trial investigating the effectiveness of a mHealth coaching programme in pregnancy and postpartum for women at high risk of developing GDM. Methods Eight hundred women will be recruited in early pregnancy from 4 clinical sites within Ireland, the UK, Spain, and Australia. Women will be screened for eligibility using the validated Monash GDM screening tool. Participants will be enrolled from 12 to 24 weeks’ gestation and randomised on a 1:1 basis into the intervention or control arm. Alongside usual care, the intervention involves mHealth coaching via a smartphone application, which uses a combination of synchronous and asynchronous video and text messaging, and allows for personalised support and goal setting with a trained health coach. The control arm receives usual care. All women and their children will be followed from early pregnancy until 12 months postpartum. The primary outcome will be a difference in maternal body mass index (BMI) of 0.8 kg/m2 at 12 months postpartum. Secondary maternal and infant outcomes include the development of GDM, gestational weight gain, pregnancy outcomes, improvements in diet, physical activity, sleep, and neonatal weight and infant growth patterns. The 5-year project is funded by the EU Commission Horizon 2020 and the Australian National Health and Medical Research Council. Ethical approval has been received. Discussion Previous interventions have not moved beyond tightly controlled efficacy trials into routine service delivery. This project aims to provide evidence-based, sustainable support that could be incorporated into usual care for women during pregnancy and postpartum. This study will contribute evidence to inform the early prevention of non-communicable diseases like obesity and diabetes in mothers and the next generation. Trial registration Australian New Zealand Clinical Trials Registry ACTRN12620001240932. Registered on 19 November 2020

Sign in / Sign up

Export Citation Format

Share Document